(Q53895543)

22 May 2018

title

The Role of Baseline HIV-1 Resistance Testing in Patients with Established Infection. (English)

1 reference

22 May 2018

author name string

Suk-Yin Chan

series ordinal

1

1 reference

22 May 2018

Todd Hulgan

series ordinal

2

1 reference

22 May 2018

Richard T. D'Aquila

series ordinal

3

1 reference

22 May 2018

publication date

1 June 2004

1 reference

22 May 2018

Current infectious disease reports

published in

1 reference

22 May 2018

volume

6

1 reference

22 May 2018

issue

3

1 reference

22 May 2018

page(s)

243-249

1 reference

22 May 2018

HIV-1 genotypic resistance patterns predict response to saquinavir-ritonavir therapy in patients in whom previous protease inhibitor therapy had failed

cites work

1 reference

Crossref

https://api.crossref.org/works/10.1007%2FS11908-004-0015-4

Use of genotypic resistance testing to guide hiv therapy: clinical impact and cost-effectiveness

21 January 2018

1 reference

Crossref

https://api.crossref.org/works/10.1007%2FS11908-004-0015-4

Brief report: primary infection with zidovudine-resistant human immunodeficiency virus type 1.

21 January 2018

1 reference

12 December 2020

Reduced antiretroviral drug susceptibility among patients with primary HIV infection

1 reference

12 December 2020

How does expert advice impact genotypic resistance testing in clinical practice?

1 reference

12 December 2020

Progressive reversion of human immunodeficiency virus type 1 resistance mutations in vivo after transmission of a multiply drug-resistant virus

1 reference

12 December 2020

Prevalence of genotypic resistance in untreated HIV patients in Spain

1 reference

12 December 2020

Prolonged retention of drug resistance mutations and rapid disease progression in the absence of therapy after primary HIV infection

1 reference

12 December 2020

A randomized study of antiretroviral management based on plasma genotypic antiretroviral resistance testing in patients failing therapy. CPCRA 046 Study Team for the Terry Beirn Community Programs for Clinical Research on AIDS.

1 reference

12 December 2020

Clinical utility of HIV-1 genotyping and expert advice: the Havana trial

1 reference

12 December 2020

Persistence and fitness of multidrug-resistant human immunodeficiency virus type 1 acquired in primary infection

1 reference

12 December 2020

Drug-selected resistance mutations and non-B subtypes in antiretroviral-naive adults with established human immunodeficiency virus infection.

1 reference

12 December 2020

Antiretroviral drug resistance testing in adults infected with human immunodeficiency virus type 1: 2003 recommendations of an International AIDS Society-USA Panel

1 reference

12 December 2020

Antiretroviral-drug resistance among patients recently infected with HIV.

1 reference

12 December 2020

Drug-resistance genotyping in HIV-1 therapy: the VIRADAPT randomised controlled trial.

1 reference

12 December 2020

Evidence of HIV-1 adaptation to HLA-restricted immune responses at a population level

1 reference

12 December 2020

Virologic and immunologic consequences of discontinuing combination antiretroviral-drug therapy in HIV-infected patients with detectable viremia.

1 reference

12 December 2020

Worldwide transmission of drug-resistant HIV

1 reference

12 December 2020

Primary HIV-1 resistance in recently and chronically infected individuals of the Italian Cohort Naive for Antiretrovirals.

1 reference

12 December 2020

Reduced susceptibility of human immunodeficiency virus type 1 (HIV-1) from patients with primary HIV infection to nonnucleoside reverse transcriptase inhibitors is associated with variation at novel amino acid sites

1 reference

12 December 2020

Phenotypic or genotypic resistance testing for choosing antiretroviral therapy after treatment failure: a randomized trial

1 reference

12 December 2020

Impact of drug resistance mutations on virologic response to salvage therapy

1 reference

12 December 2020

Antiretroviral drug resistance testing in adults with HIV infection: implications for clinical management. International AIDS Society--USA Panel.

1 reference

12 December 2020

Immune control of HIV-1 after early treatment of acute infection

1 reference

12 December 2020

Time trends in primary HIV-1 drug resistance among recently infected persons

1 reference

12 December 2020

Transmission of zidovudine-resistant HIV-1

1 reference

12 December 2020

Antiretroviral drug resistance testing in adult HIV-1 infection: recommendations of an International AIDS Society-USA Panel.

1 reference

12 December 2020

Zidovudine resistance and HIV-1 disease progression during antiretroviral therapy. AIDS Clinical Trials Group Protocol 116B/117 Team and the Virology Committee Resistance Working Group

1 reference

12 December 2020

Analysis of prevalence of HIV-1 drug resistance in primary infections in the United Kingdom

1 reference

12 December 2020

Usefulness of monitoring HIV drug resistance and adherence in individuals failing highly active antiretroviral therapy: a randomized study (ARGENTA).

1 reference

12 December 2020

10.1007/S11908-004-0015-4

Identifiers

DOI

1 reference

22 May 2018

1 reference

22 May 2018